Showing 851-860 of 1784 results for "".
Subscription Revenue Strategies for Aesthetic Practices
https://reachmd.com/ma-issues-index/may-jun-2026-issue/subscription-revenue-strategies-for-aesthetic-practices/59175/Boost your bottom line by transforming first-time visits into lifetime members.Confronting Antisemitism in Medicine and Dermatology
https://reachmd.com/ma-issues-index/march-april-2026-issue/confronting-antisemitism-in-medicine-and-dermatology/56632/Why rising hate demands action from physicians and practice leadersA Strategic Framework for Technology Adoption in Aesthetic Practices
https://reachmd.com/programs/modern-aesthetics/a-strategic-framework-for-technology-adoption-in-aesthetic-practices/56628/How disciplined evaluation, operational alignment, and patient-centered decision-making drive sustainable growth across multi-location aesthetic organizationsEvaluating EFS and Surgical Outcomes in Resectable NSCLC: Insights From a Clinical Trial
https://reachmd.com/programs/medical-industry-feature/evaluating-efs-and-surgical-outcomes-in-resectable-nsclc-insights-from-a-clinical-trial/39813/Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
https://reachmd.com/programs/cme/vous-prescrivez-uniquement-des-antihistaminiques-pour-traiter-les-patients-atteints-de-pa-mrc-il-est-temps-de-revoir-votre-approche/56888/Examinez un cas clinique réel de Pa-MRC et explorez les options thérapeutiques actuelles, y compris l’utilisation de la difélikéfaline, recommandée par les lignes directrices, chez les patients sous hémodialyse.Managing Mental Health in the Times of Pandemic
https://reachmd.com/programs/covid-19-frontlines/managing-mental-health-in-the-times-of-pandemic/11409/One of the many impacts of the COVID-19 pandemic is the silent spread of anxiety and depression among our patients. How can we help them cope?Using Data to Fight a Pandemic: A Look at the COVID-19 Research Database
https://reachmd.com/programs/covid-19-frontlines/using-data-to-fight-a-pandemic-a-look-at-the-covid-19-research-database/11513/Here to walk us through this revolutionary development is the Scientific Committee Chair for the academic arm of the COVID-19 research database.Multiple Eruptive Myxoid Dermatofibromas in Patient With History of HIV
https://reachmd.com/programs/practical-dermatology/multiple-eruptive-myxoid-dermatofibromas-in-patient-with-history-of-hiv/24216/Multiple eruptive dermatofibromas, a rare presentation of dermatofibroma, has been associated with altered immunity such as HIV/AIDS.Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
https://reachmd.com/programs/cme/do-not-delay-timing-triggers-and-identifying-the-right-patient-for-additional-therapies-in-hfref/54633/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
https://reachmd.com/programs/cme/translating-evidence-into-action-nonsteroidal-mras-in-patients-with-hf/49259/Explore the practical implementation of finerenone in HFmrEF and HFpEF, including guideline updates, safety monitoring, and early initiation strategies.